Showing results (2381-2390 of 5,262) with videos related to

Sort By:
Pageof 527
Oncology|January 5, 2017
The Maze of Diagnosing Hemophagocytic Lymphohistiocytosis: Single-Center Experience of a Series of 6 Clinical CasesMaher Hanoun, Ulrich Dührsen
Oncology|January 5, 2017
Characterization of Conversion Chemotherapy for Secondary Surgical Resection in Colorectal Cancer Patients with Lung MetastasesHiroaki Nozawa, Soichiro Ishihara, Kazushige Kawai, et al.
Oncology|December 14, 2016
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center StudyGiuseppe Cicero, Rossella De Luca, Patrizia Dorangricchia, et al.
Oncology|December 16, 2016
Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver DiseaseSatoru Hagiwara, Naoshi Nishida, Tomohiro Watanabe, et al.
Oncology|December 22, 2007
CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver diseaseKenichi Takayasu, Yukio Muramatsu, Yasunori Mizuguchi, et al.
Oncology|December 22, 2007
Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic imagesYasunori Minami, Masatoshi Kudo, Hobyung Chung, et al.
Oncology|January 1, 1975
Boron neutron capture therapy of cerebral gliomas. II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomasE I Tolpin, G R Wellum, F C Dohan, et al.
Oncology|December 22, 2007
PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resectionDo Young Kim, Yong Han Paik, Sang Hoon Ahn, et al.
Oncology|December 22, 2007
Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patientsHiroshi Kasugai, Yukio Osaki, Hiroko Oka, et al.
Oncology|December 22, 2007
What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography?Pei Zhou, Masatoshi Kudo, Yasunori Minami, et al.
Pageof 527